Journal article

Reactivation of hepatitis B virus with mutated hepatitis B surface antigen in a liver transplant recipient receiving a graft from an antibody to hepatitis B surface antigen- and antibody to hepatitis B core antigen-positive donor


Authors listBlaich, Annette; Manz, Michael; Dumoulin, Alexis; Schuettler, Christian G.; Hirsch, Hans H.; Gerlich, Wolfram H.; Frei, Reno

Publication year2012

Pages1999-2006

JournalTransfusion

Volume number52

Issue number9

ISSN0041-1132

eISSN1537-2995

Open access statusGreen

DOI Linkhttps://doi.org/10.1111/j.1537-2995.2011.03537.x

PublisherWiley


Abstract
BACKGROUND: Fresh-frozen plasma (FFP) may contain antibodies to hepatitis B surface antigen (HBsAg, anti-HBs). These anti-HBs may lead to a misinterpretation of the actual hepatitis B immune status. Furthermore, they may not only confer protection against hepatitis B virus (HBV), but may also favor the selection of HBsAg mutants. CASE REPORT: We report a case of de novo HBV infection in a HBV-naive recipient with alcoholic liver disease, who received a liver from a donor with antibodies to hepatitis B core antigen (HBcAg, anti-HBc) and anti-HBs. RESULTS: A lookback investigation revealed the following: 1) Due to anti-HBs passively acquired through FFP, the recipient was considered immune to HBV and did not receive anti-HBV prophylaxis. 2) Within 1 year after transplantation he developed hepatitis B in absence of any elevated liver enzymes after the anti-HBs by FFP declined. 3) Despite an infection with HBV-containing wild-type HBcAg, the patient did not seroconvert to anti-HBc positivity. 4) The replicating HBV encoded two HBsAg mutations, first sQ129R and 4 months later sP127S. They map to the highly conserved a determinant of the HBsAg loop. CONCLUSION: 1) Passive transfer of anti-HBs from FFP led to an erroneous pretransplant diagnosis of HBV immunity when the patient was in fact HBV-naive. 2) HBsAg mutations might have been selected in escape from donor's actively produced anti-HBs and the recipient's anti-HBs by FFP might have favored this selection. 3) It is doubtful whether hepatitis B immunoglobulin could have prevented the reactivation. 4) Antiviral prophylaxis would have been crucial.



Citation Styles

Harvard Citation styleBlaich, A., Manz, M., Dumoulin, A., Schuettler, C., Hirsch, H., Gerlich, W., et al. (2012) Reactivation of hepatitis B virus with mutated hepatitis B surface antigen in a liver transplant recipient receiving a graft from an antibody to hepatitis B surface antigen- and antibody to hepatitis B core antigen-positive donor, Transfusion, 52(9), pp. 1999-2006. https://doi.org/10.1111/j.1537-2995.2011.03537.x

APA Citation styleBlaich, A., Manz, M., Dumoulin, A., Schuettler, C., Hirsch, H., Gerlich, W., & Frei, R. (2012). Reactivation of hepatitis B virus with mutated hepatitis B surface antigen in a liver transplant recipient receiving a graft from an antibody to hepatitis B surface antigen- and antibody to hepatitis B core antigen-positive donor. Transfusion. 52(9), 1999-2006. https://doi.org/10.1111/j.1537-2995.2011.03537.x



Keywords


absenceADVISORY-COMMITTEEBLOOD-DONORIMMUNIZATIONRECOMMENDATIONSTRANSFUSION

Last updated on 2025-10-06 at 10:08